Navigation Links
Study Shows Combination Therapy Incorporating AVODART(R) and Tamsulosin Provides Continuous Symptom Improvement Over 2 Years
Date:9/4/2007

a class of medicines that relaxes muscles in the bladder and prostate.

"This study provides important new data to guide initial therapy for men with symptomatic BPH," said Claus Roehrborn, M.D., Professor and Chairman, Department of Urology, UT Southwestern Medical Center at Dallas and CombAT principal investigator. "This is the first time we have seen a benefit for combination therapy over monotherapy during the first 12 months of treatment."

CombAT Two-Year Results

The findings reported today are intermediate results from a study that remains active. Researchers will issue a final report at the end of four years regarding the efficacy of AVODART, tamsulosin, and combination therapy in reducing the risk of symptomatic disease progression and the risk of urinary retention (AUR) and prostate surgery in men with moderate-to-severe enlarged prostate symptoms.

Poster presentation: "The effects of dutasteride, tamsulosin, and combination therapy on lower urinary tract symptoms and Qmax in men with BPH and prostatic enlargement"

According to this analysis, the two-year primary endpoint was achieved in the CombAT study. Symptom improvement was measured using the International Prostate Symptom Score (IPSS), a validated assessment questionnaire recommended by the American Urological Association (AUA). Over 24 months, AVODART and tamsulosin combination therapy provided a significantly greater (p < 0.001) improvement in symptoms (IPSS) from baseline (6.2 units) than either AVODART (4.9 units) or tamsulosin (4.3 units) treatment alone. In fact, the CombAT study demonstrated the benefit of combination therapy over both monotherapies in the first 12 months of treatment. With combination therapy, patients experienced continuous improvement of symptoms throughout the two years of the study.

Poster presentation: "Dutasteride provides greater improvement in symptoms and Qmax than tamsulosin in men with moderate-to-severe symptoms of BPH and prosta
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... N.Y. , Dec. 24, 2014 Kinex ... dosed with KX2-361 at Roswell Park Cancer Institute. ... small molecule drug that has shown potent inhibitory activity ... including those that are resistant to Temozolomide (T98G), the ... glioma. In a well-established brain tumor mouse model, KX2-361 ...
(Date:12/24/2014)... FARMINGTON, Conn. , Dec. 24, ... PTN), a biopharmaceutical company developing targeted, receptor-specific peptide ... unmet medical need and commercial potential, today announced ... of 2,050,000 shares of its common stock and ... its common stock.  Funds under the management of ...
(Date:12/24/2014)... 2014 ResMed (NYSE: RMD ) today ... Chinese medical device manufacturer BMC Medical Co., Ltd. ... masks listed below infringe ResMed,s patents, and entered an order ... the United States : , ... , Willow nasal pillows mask , iVolve full face ...
Breaking Medicine Technology:Kinex Pharmaceuticals Announces First Patient Dosed with KX2-361 in a Phase 1 Clinical Study 2Kinex Pharmaceuticals Announces First Patient Dosed with KX2-361 in a Phase 1 Clinical Study 3Palatin Completes $20 Million Equity and $10 Million Debt Financings 2Palatin Completes $20 Million Equity and $10 Million Debt Financings 3Palatin Completes $20 Million Equity and $10 Million Debt Financings 4ResMed Wins Patent Infringement Lawsuit Against Chinese Manufacturer BMC Medical 2
... SALT LAKE CITY, June 04, 2007 /PRNewswire-FirstCall/ -- ... a 340 patient,randomized Phase III clinical trial testing ... presented at the annual,American Society of Clinical Oncology ... results of this clinical study,which was conducted at ...
... III Data Presented at ASCO -, CHICAGO, ... that Soliris(TM) (eculizumab), a new treatment for,paroxysmal ... , is effective in patients diagnosed with ... (AA) or myelodysplastic,syndromes (MDS). Soliris significantly reduced ...
Cached Medicine Technology:Hyperthermia Plus Chemotherapy Nearly Doubles Disease-Free Survival,Compared to Chemotherapy Alone for Sarcoma Cancer Patients 2Hyperthermia Plus Chemotherapy Nearly Doubles Disease-Free Survival,Compared to Chemotherapy Alone for Sarcoma Cancer Patients 3Soliris Effective in PNH Patients With History of Aplastic Anemia,and Myelodysplastic Syndromes 2Soliris Effective in PNH Patients With History of Aplastic Anemia,and Myelodysplastic Syndromes 3Soliris Effective in PNH Patients With History of Aplastic Anemia,and Myelodysplastic Syndromes 4Soliris Effective in PNH Patients With History of Aplastic Anemia,and Myelodysplastic Syndromes 5Soliris Effective in PNH Patients With History of Aplastic Anemia,and Myelodysplastic Syndromes 6Soliris Effective in PNH Patients With History of Aplastic Anemia,and Myelodysplastic Syndromes 7
(Date:12/26/2014)... Yisrayl Hawkins, Pastor at The House of Yahweh in ... the Ferguson, Missouri unrest. Yisrayl starts his letter by showing ... it has only increased. , He continues in his ... there is a very specific reason for mankind and covers ... set of rules, or Laws that if followed would ensure ...
(Date:12/26/2014)... PA (PRWEB) December 26, 2014 Pentec ... Work in the state of Pennsylvania for 2014. The ... first statewide programs of its kind in the country. ... Foundation, the Pennsylvania Department of Community and Economic Development, ... Resource Management and the Central Penn Business Journal. ...
(Date:12/25/2014)... The click strand woven bamboo flooring ... Today, the business announces a click strand woven ... 30, 2015. , Click strand woven bamboo flooring ... a well-known brand in the bamboo industry. It ... reliable bamboo flooring supplier. , “We are happy ...
(Date:12/25/2014)... 26, 2014 Recently, iFitDress.com, the popular online ... has announced its new selection of black one-shoulder cocktail ... sale now; they are available at discounted prices, up to ... promotion will last for three weeks only. You know, we ... who are interested in our new items can visit our ...
(Date:12/25/2014)... December 25, 2014 Helen Harris’ RP ... Woodland Hills, California after an 8 year battle with ... Christmas Eve evening in her home in Woodland Hills ... breast cancer. , As the founder ... years, she pioneered and championed many of today's greatest ...
Breaking Medicine News(10 mins):Health News:Yisrayl Hawkins Pleads for Peace in Ferguson and Beyond in New Open Letter 2Health News:Pentec Health Ranks Fourteenth on The Best Places to Work in PA for 2014 2Health News:Pentec Health Ranks Fourteenth on The Best Places to Work in PA for 2014 3Health News:BambooFlooringChina.com: click strand woven bamboo flooring promotion valid until Jan. 30, 2015. 2Health News:iFitDress.com: Black One-Shoulder Cocktail Dresses for 2015 2Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 2Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 3Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 4
... ... to promote their first documentary film project entitled Now Serving. Now Serving will highlight the lives ... , ... Box Media LLC announces the launch of their blog site, My Apple Box , which ...
... ... that MedFusion®, of Dallas, Texas, has signed a business agreement to license laboratory ... ... 17, 2010 -- Sunquest Information Systems, Inc. ® , a leading provider ...
... ... can talk with an animated character - called an Avatar - who can help you make ... playing the role of an irate partner. , ... New York, NY (PRWEB) March 17, 2010 -- Imago,s new "marriage counseling" Avatar ...
... ... and potential physician leaders, through New York University,s Stern School of Business. , ... (Vocus) March 16, 2010 ... for its current and potential physician leaders. The 10-session program of New York University’s ...
... (Nasdaq: JAZZ ) announced today that Robert Myers , the company,s President, will present at the Barclays Capital 2010 Global Healthcare Conference on Wednesday, March 24, 2010 ... ... ... ...
... , March 16 TeamHealth Holdings, Inc. ("TeamHealth") ... of outsourced healthcare professional staffing and administrative services to hospitals ... today announced that its management will be presenting at the ... 2010 , at the Loews Miami Hotel, Florida . ...
Cached Medicine News:Health News:Announcing the Launch of My Apple Box 2Health News:Sunquest Information Systems Enters into Business Relationship with MedFusion of Dallas 2Health News:Avatar Meets Marriage Counseling; Take Imago Therapy for a Test Drive 2Health News:Avatar Meets Marriage Counseling; Take Imago Therapy for a Test Drive 3Health News:Summit Medical Group Prepares Physicians for Future Leadership 2Health News:Jazz Pharmaceuticals to Present at the Barclays Capital 2010 Global Healthcare Conference 2Health News:TeamHealth Holdings, Inc., to Present at Barclays Capital Global Healthcare Conference 2Health News:TeamHealth Holdings, Inc., to Present at Barclays Capital Global Healthcare Conference 3
One step Immunochromatographic Assay for the detection of Respiratory Syncytial Virus...
Rapid Immunoassay for the detection of Respiratory Syncytial Virus....
Rapid, visual assay for the presumptive qualitative detection of Respiratory Syncytial Virus (RSV) directly from nasopharyngeal specimens in neonatel and pediatric patients....
... The BD Directigen EZ RSV Test utilizes ... reagent and one device for rapid RSV detection. ... a method whereby dried reagents have already ... reduced to a two-step process, with clear-cut results ...
Medicine Products: